1. Harapan H, Itoh N, Yufika A, Winardi W, Keam S, Te H, et al. Coronavirus disease 2019 (COVID-19): a literature review. J Infect Public Health. 2020; 13(5):667–673. PMID:
32340833.
Article
2. Chung JY, Thone MN, Kwon YJ. COVID-19 vaccines: the status and perspectives in delivery points of view. Adv Drug Deliv Rev. 2021; 170:1–25. PMID:
33359141.
Article
3. Talley NJ, Shorter RG, Phillips SF, Zinsmeister AR. Eosinophilic gastroenteritis: a clinicopathological study of patients with disease of the mucosa, muscle layer, and subserosal tissues. Gut. 1990; 31(1):54–58. PMID:
2318432.
Article
4. Tian XQ, Chen X, Chen SL. Eosinophilic gastroenteritis with abdominal pain and ascites: A case report. World J Clin Cases. 2021; 9(17):4238–4243. PMID:
34141786.
Article
5. Bischoff SC, Ulmer FA. Eosinophils and allergic diseases of the gastrointestinal tract. Best Pract Res Clin Gastroenterol. 2008; 22(3):455–479. PMID:
18492566.
Article
6. Yun MY, Cho YU, Park IS, Choi SK, Kim SJ, Shin SH, et al. Eosinophilic gastroenteritis presenting as small bowel obstruction: a case report and review of the literature. World J Gastroenterol. 2007; 13(11):1758–1760. PMID:
17461485.
Article
7. Mishra A, Hogan SP, Brandt EB, Rothenberg ME. IL-5 promotes eosinophil trafficking to the esophagus. J Immunol. 2002; 168(5):2464–2469. PMID:
11859139.
Article
8. Mishra A, Rothenberg ME. Intratracheal IL-13 induces eosinophilic esophagitis by an IL-5, eotaxin-1, and STAT6-dependent mechanism. Gastroenterology. 2003; 125(5):1419–1427. PMID:
14598258.
Article
9. Collins MH. Histopathologic features of eosinophilic esophagitis and eosinophilic gastrointestinal diseases. Gastroenterol Clin North Am. 2014; 43(2):257–268. PMID:
24813514.
Article
10. Zhang M, Li Y. Eosinophilic gastroenteritis: a state-of-the-art review. J Gastroenterol Hepatol. 2017; 32(1):64–72.
Article
11. Michet CJ Jr, Rakela J, Luthra HS. Auranofin-associated colitis and eosinophilia. Mayo Clin Proc. 1987; 62(2):142–144. PMID:
3807438.
Article
12. Riedel RR, Schmitt A, de Jonge JP, Hartmann A. Gastrointestinal type 1 hypersensitivity to azathioprine. Klin Wochenschr. 1990; 68(1):50–52. PMID:
2308269.
Article
13. Ravi S, Holubka J, Veneri R, Youn K, Khatib R. Clofazimine-induced eosinophilic gastroenteritis in AIDS. Am J Gastroenterol. 1993; 88(4):612–613.
14. Lee JY, Medellin MV, Tumpkin C. Allergic reaction to gemfibrozil manifesting as eosinophilic gastroenteritis. South Med J. 2000; 93(8):807–808. PMID:
10963515.
Article
15. Barak N, Hart J, Sitrin MD. Enalapril-induced eosinophilic gastroenteritis. J Clin Gastroenterol. 2001; 33(2):157–158. PMID:
11468446.
Article
16. Shakeer VK, Devi SR, Chettupuzha AP, Mustafa CP, Sandesh K, Kumar SK, et al. Carbamazepine-induced eosinophilic enteritis. Indian J Gastroenterol. 2002; 21(3):114–115. PMID:
12118924.
17. Tomiyasu H, Komori T, Ishida Y, Otsuka A, Kabashima K. Eosinophilic gastroenteritis in a melanoma patient treated with nivolumab. J Dermatol. 2021; 48(10):E486–E487. PMID:
34151453.
Article
18. Wienand B, Sanner B, Liersch M. Eosinophilic gastroenteritis as an allergic reaction to a trimethoprim-sulfonamide preparation. Dtsch Med Wochenschr. 1991; 116(10):371–374. PMID:
2001640.
Article
19. de Las Vecillas L, López J, Morchón E, Rodriguez F, Drake M, Martino M. Viral-like reaction or hypersensitivity? Erythema multiforme minor reaction and moderate eosinophilia after the Pfizer-BioNTech BNT162b2 (mRNA-Based) SARS-CoV-2 vaccine. J Investig Allergol Clin Immunol. 2021; 32(1):77–78.
Article
20. Ishizuka K, Katayama K, Kaji Y, Tawara J, Ohira Y. Non-episodic angioedema with eosinophilia after BNT162b2 mRNA COVID-19 vaccination. QJM. 2021; 114(10):745–746. PMID:
34546346.
Article
21. de Montjoye L, Marot L, Baeck M. Eosinophilic cellulitis after BNT162b2 mRNA Covid-19 vaccine. J Eur Acad Dermatol Venereol. 2022; 36(1):e26–e28. PMID:
34547138.
Article
22. O’Connor T, O’Callaghan-Maher M, Ryan P, Gibson G. Drug reaction with eosinophilia and systemic symptoms syndrome following vaccination with the AstraZeneca COVID-19 vaccine. JAAD Case Rep. 2022; 20:14–16. PMID:
34931172.
Article
23. Kaikati J, Ghanem A, El Bahtimi R, Helou J, Tomb R. Eosinophilic panniculitis: a new side effect of Sinopharm COVID-19 vaccine. J Eur Acad Dermatol Venereol. 2022; 36(5):e337–e339. PMID:
35020234.
Article
24. Lindsley AW, Schwartz JT, Rothenberg ME. Eosinophil responses during COVID-19 infections and coronavirus vaccination. J Allergy Clin Immunol. 2020; 146(1):1–7. PMID:
32344056.
Article